Uni-Bio Science Group is a Hong Kong-listed biopharmaceutical operating company and corporate strategic investor. Based in Hong Kong, it is most relevant to founders as a life sciences strategic backer with later-stage U.S. venture activity. Its operating focus spans regenerative medicine, synthetic biology, biologics, generics and medical aesthetics, aligning its investment relevance with Biotechnology, Life Sciences, Pharmaceuticals, Medical Devices and Beauty.